Physician profile
Jose Roca
NPI 1184619157
$1,405.47
in general payments reported to CMS, 2019-2025
13 companies · $47.17 in 2025
The $47.17 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $167 · 2021: $126 · 2022: $65.51 · 2023: $272 · 2024: $169 · 2025: $47.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371 · Education: $94.99 · Travel and Lodging: $23.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.80 |
| Education | $94.99 |
| Travel and Lodging | $23.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $266.27 | 2019-2024 | Opsumit, Uptravi |
| Abbott Laboratories | $231.55 | 2019-2021 | |
| Shockwave Medical, INC | $191.67 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $138.51 | 2019-2025 | |
| United Therapeutics Corporation | $126.43 | 2019-2020 | |
| Boston Scientific Corporation | $117.47 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.01 | 2019-2024 | Jardiance |
| Cardiovascular Systems INC. | $65.51 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.32 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $49.84 | 2019-2020 | |
| Pfizer INC. | $38.35 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.73 | 2020 | |
| Abbvie INC. | $21.81 | 2023 | Qulipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Roca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.